ABSTRACT
INTRODUCTION
In August 2007 doctor Zola Skweyiya, the Social Development Minister, stated that substance abuse in South Africa is reaching crisis proportions as the following statistics reveal: At least seven percent of the inhabitants are alcohol dependent, whereas 31 percent are at risk of developing serious drinking problems. More than 800 000 South Africans use 123 metric tons of cannabis per year, whereas 265 000 consume five metric tons of cocaine per annum. An estimated 1.2 million citizens furthermore abuse amphetamines (Hosken, 2007:1) . These alarming statistics emphasise not only the need for effective rehabilitation programmes, but also the necessity that addicts successfully complete treatment. Premature treatment termination is, however, a major problem at drug addiction treatment centres and has serious prognostic and financial implications (King & Canada, 2004:189) . Gillmore, Lash, Foster and Blosser (2001:524) found that on average 50% of patients drop out of rehabilitation programmes within the first five weeks of admission.
Addicts who drop out have a poorer prognosis than those who complete treatment programmes. In this regard Gillmore et al. (2001:525) state that treatment drop-outs have the same treatment outcomes as untreated addicts. The same authors furthermore found that interventions aimed at improving adherence to rehabilitation programmes reduced readmission by 66% over a six-month period (Gillmore et al. 2001:537) . Identifying factors contributing to treatment non-adherence can therefore guide the clinician to design special interventions to prevent patient attrition. In this regard the article intends to give an overview of factors leading to treatment drop-out and then to explore the role of five possible factors contributing to this problem. To add to the existing body of knowledge, the authors investigated patterns of supplementary psychiatric and general scheduled medication use, legal history, and DSM-IV-TR Axis I and II co-morbidity as predictors of non-adherence in rehabilitation programmes. This study was conducted at the SHARP inpatient treatment centre in Johannesburg. This rehabilitation centre deals with a wide range of substance addiction including, alcohol, amphetamines, hallucinogens, opioids, cannabis, inhalants and polysubstances. The SHARP centre employs the Minnesota rehabilitation model which includes the 12-step principles of Alcoholics Anonymous (AA) and Narcotics Anonymous (NA).
PREDICTORS OF PREMATURE TREAT-MENT DROP-OUT

Demographic predictors
Age
Research indicates that the role of age in treatment drop-out is unclear. Brown, O'Grady, Farrell, Flechner and Nurco (2001:147) found that age does not significantly distinguish treatment adherent from treatment non-adherent groups. Slesnick (2001:411-2) , however, found that adolescent addicts tend to drop out of treatment programmes at an early stage. The attrition rate is so high that only 10-18% of youths complete rehabilitation programmes. She also found that such patients are less motivated to change and are difficult to engage in therapy. Similar findings were obtained by Agosti, Nunes and Ocepeck-Welikson (1996:29) , showing that drop-outs among cocaine addicts tend to be younger and have an earlier onset of substance abuse.
Gender
Some studies show that women have poorer treatment retention, whereas other researchers fail to find a gender difference in adherence (King et al. 2004:190) . Many samples, however, contain more men than women, and men are more often coerced into treatment, which might account for compliance rates being biased towards males. Haller, Miles and Dawson (2002:431) further report that lack of resources such as inadequate childcare contribute to the fact that women prematurely terminate addiction treatment. Sannibale, Hurkett, Van den Bossche, O'Connor, Zador, Capus, Gregory and McKenzie (2003:187) found that older female patients are more likely to adhere to aftercare programmes than younger male patients. Similarly Copeland and Hall (1992:888) found that women under the age of 25 are more likely to drop out of rehabilitation programmes.
Combination of age and gender
Ethnicity
Once again mixed results are found in the literature.
Some studies indicate that ethnic minorities (for example, African and Hispanic Americans) tend to drop out of rehabilitation sooner than their Caucasian counterparts (Wickizer, Maynard, Atherly, Frederick, Koepsell, Krupski & Stark, 1994:216; Agosti et al. 1996:29) . Other surveys, however, contradict this finding (King et al. 2004:190) .
It would seem that racial bias could play a part in early drop-out of ethnic minorities. In this regard Wickizer et al. (1994:216) state: "Ethnicity per se might not be as important as the fit between one's ethnic group and the norms and culture of the programme."
Education
Findings about treatment compliance are fairly consistent, indicating that better educated patients tend to complete treatment more readily (Wickizer et al. 1994:219) . Low levels of education would then relate to treatment non-engagement (King et al. 2004:189) .
Socio-economic status
Unemployment predicts poor treatment adherence (Claus & Kindleberger, 2002:25; King et al. 2004:189) . Similar findings were reported by Copeland and Hall (1992:889) who state that "unemployment is the strongest predictor of treatment drop-out in women". Similar findings show that lower-income groups tend to be less likely to complete drug rehabilitation programmes (Vendetti, McRee, Miller, Christiansen & Herrell, 2002:126) .
Health status
Patients with serious health problems related to drinking, for example, cirrhosis of the liver, tend to be more treatment compliant (Wickizer et al. 1994:216) . In this regard it seems that severe impairment in health might serve as a motivating factor in treatment adherence.
Patterns of prescription medication use
No mention was found in the literature concerning the relationship between past and present patterns of prescription medication use and pre-mature drop-out. In this regard this study makes a new contribution to the field by hypothesising that an addict's history of using psychiatric and other scheduled medication might have an influence on treatment compliance.
Relationship status and social support
This contributing factor yet again yields mixed results.
A large body of research indicates that social support, or the lack of it, does influence treatment adherence.
Lack of significant social support predicts poor treatment retention, whereas the presence of a supportive social environment prevents premature drop-out (Kelly & Moos, 2003:241; King et al. 2004:190) . Researchers furthermore indicate that being single relates to treatment attrition, whereas being married with dependants at home relates to treatment completion (Wickizer et al. 1994:216; Kelly et al. 2003:244) . The importance of social support was, however, contradicted by the findings of Brown et al. (2001:148) who failed to find a relationship between quality of relationships and treatment adherence.
Religiosity
Religious conviction also shows contradictory results. Brown et al. (2001:148) , for example, failed to find a link between religiosity and treatment adherence, whereas Kelly et al. (2003:344) report that strong religious beliefs relate to treatment adherence.
Legal history
A history of multiple drug-related arrests is associated with treatment drop-out (King et al. 2004:190) . Claus et al. (2002:25) similarly found that prisoners on probation are more likely to prematurely terminate rehabilitation treatment. This finding was challenged by Brown et al. (2001:156) who found that patients with long histories of criminal activity and a higher incidence of arrests are more likely to be adherent in out-patient 12-step programmes.
Patterns and intensity of substance abuse
In terms of substance of choice, no clear predictors of treatment adherence emerge. There are indications that addiction to cocaine, a long history of substance abuse and a greater number of previous treatments relate to non-adherence (King et al. 2004:190) . Agosti et al. (1996:29) obtained similar findings, showing that intravenous or freebase cocaine users tend to have a high drop-out rate.
The number of years of heroin abuse also has a negative effect on treatment completion for first-time rehabilitation patients (Ravndal, Vaglum & Lauritzen, 2005:180) . Copeland et al. (1992:889) reported similar findings by stating that women who nominate heroin as drug of choice tend to drop out of rehabilitation programmes.
Poly-substance abusers have lower adherence to after-care treatment and also have the poorest prognosis (Sannibale et al. 2003:188) . Brown et al. (2001:154) , nevertheless, found that patients with a long history of serious drug abuse more regularly attend 12-step treatment programmes. This study also showed that serious long-term abusers of cocaine, heroin and other opiates tend to adhere better to treatment.
Treatment modality
Findings consistently show that the drop-out rate is higher in outpatient programmes than in in-house treatment programmes (Claus et al. 2002:26) .
Motivation, attitudes and expectations
Mixed results are obtained from psychometric tests concerning the link between motivation, attitudes and expectations towards treatment and treatment adherence (Gillmore et al. 2001:525) . Claus et al. (2002:30) claim that internal motivation to change does not have a significant effect on treatment adherence, whereas Gillmore et al. (2001: 524) found that candid acknowledgement of addiction is not an accurate predictor of treatment adherence.
Measures on the Negative Treatment Indicator Scale of the MMPI-2
Addicts who score high on the Negative Treatment Indicator Scale of the MMPI-2 not only tend to drop out of rehabilitation programmes, but they also have a tendency not to return to treatment. High scorers on this scale have negative attitudes towards mental health programmes and health care professionals in general.
They are reluctant to discuss their problems openly and do not believe that they can be helped or understood. High scorers are apathetic, have a tendency to give up before trying, and do not believe that rehabilitation is possible. They are consequently not motivated to change their lives (Gillmore et al. 2001:524-8) .
Co-morbidity with other psychopathology
Co-morbidity with other forms of DSM-IV-TR pathology is once again not a clear predictor of pre-mature treatment drop-out. Brown et al. (2001:154) , for example, did not find significant differences in co-morbid psychopathology between treatment adherent and treatment non-adherent groups.
Axis I
Other studies nevertheless indicate that patients with anxiety-based disorder co-morbidity tend to adhere better to treatment programmes (Gillmore et al. 2001:526) . In the same way Claus et al. (2002:25-6) report that patients suffering from anxiety concurrent with depression are more likely to complete rehabilitation programmes. Depression with somatisation, on the other hand, is associated with premature termination (Haller et al. 2002:431) .
The findings concerning depression without anxiety are not consistent. Depression accompanied by a tendency to avoid responsibility, for instance, seems to lead to treatment non-adherence (King et al. 2004:190) . Haller et al. (2002:435) furthermore confirm that major depression is associated with premature drop-out. These findings were, however, contradicted by Brown et al. (2001:154) and Agosti et al. (1996:29) , who failed to find a link between treatment attrition and depression.
Hypomania predictably relates to premature drop-out (Gillmore et al. 2001:525) , whereas addicts in the psychotic range also tend to have higher treatment attrition (Haller et al. 2002:435) .
Personality disorders
From the literature it is evident that the co-morbidity of substance abuse and personality disorders is very high.
In this regard Ball, Cobb-Richardson, Connolly, Bujosa and O'Neall (2005:371) state: "Across studies involving different samples, settings and methods of assessment, more than half of treated substance abusers have at least one personality disorder, and the majority has more than one such disorder." In this regard Ball et al. (2005:375) state that borderline-and anti-social personality disorders often co-occur with substance abuse.
Establishing the relationship of Axis II co-morbidity with treatment compliance, however, seems to be a complex matter.
Once again the literature reports mixed results, as some authors found that the presence of anti-social, borderline and histrionic personality traits contribute to nonadherence in rehabilitation programmes (Gillmore et al.2001:525) . Others, conversely, failed to confirm this hypothesis (Ravndal et al. 2005:183) . Haller et al. (2002:431) , nevertheless argue that women suffering from Cluster B disorders are able to complete rehabilitation if a sufficient "holding environment is maintained". Claus et al. (2002:25) found that patients reporting sexual and physical abuse in childhood are more likely to drop out of treatment. Apparently childhood abuse has a negative effect on the development of social skills, which in turn reduces the patient's ability to co-operate in treatment programmes. Interestingly, however, Copeland et al. (1992:888) found that women who suffered from sexual assault in adulthood tended to be treatment adherent.
Other psychological factors
Sexual abuse
EVALUATION OF THE LITERATURE
Perusing the literature, it becomes evident that most of the findings attempting to predict premature drop-out are contradictory. Disparate results are probably due to "differences in subject populations, methods and measures, and definitions of treatment completion" (Wickizer et al. 1994:215) . Many studies are also based on one treatment episode only (Wickizer et al. 1994:220) .
PRACTICAL IMPLICATIONS OF THE LIT-ERATURE
Identifying special risk factors of treatment drop-out, allows clinicians to "place such clients in appropriate or targeted programmes" (King et al. 2004:190) to prevent treatment non-adherence.
RESEARCH METHODS
Problem statement and research design
The current study endeavoured not only to verify some 
Variables
Independent variable
The independent variable category treatment adherent indicates that patients completed the full drug rehabilitation programme, which implies that they completed 13 weeks of the 12-step in-patient treatment programme at the SHARP centre.
The independent variable category treatment non-adherent indicates that patients did not complete the full drug rehabilitation programme, but dropped out within the first seven weeks.
Dependent variables
Five dependent variables were employed in the study.
Each of these variables had two or more distinct categories. A brief description of these will be given in the following section.
Dependent variable A: Legal history
Legal history refers to the participant's criminal record.
Three categories were assigned in this case:
• no criminal record (the patient had never been arrested or convicted for a criminal activity); • criminal record (the patient had been arrested and had been found guilty of the crime); and • arrested, but no criminal record (the patient had been arrested, but had not been found guilty of the felony).
Dependent variable B: Supplementary scheduled medication current
This variable refers to scheduled medication taken by the patient during the treatment programme, as prescribed by a medical doctor or psychiatrist. Only three categories were found in the sample:
• psychiatric drugs;
• psychiatric drugs and general prescription medication for valid medical or psychiatric conditions; and • none.
Dependent variable C: Supplementary scheduled medication on admission
This variable refers to additional prescription medication used by the patient on admission to the rehabilitation programme. This category excludes the patient's drug-of-choice (substance addiction). Only three categories were found in the sample:
• psychiatric drugs and general scheduled medication for medical or psychiatric conditions; and • none.
Dependent variable D: Co-morbidity Axis I
This variable refers to the patient's DSM-IV-TR Axis I co-morbidity. Only five types of co-morbid Axis I pathology were found in the sample. Six categories were therefore assigned:
• Anxiety-based disorders (this category included anxiety, somatoform and dissociative disorders); • Mood disorders (this category included both unipolar and bipolar mood disturbances); • Psychosis;
• Eating disorders (including anorexia nervosa and bulimia);
• Adult attention deficit disorder; and
• None (no Axis I co-morbidity).
Dependent variable E: Co-morbidity Axis II -Cluster B
This variable refers to the presence of co-morbid DSM-IV-TR personality disorders. Only two Cluster B categories were found in the sample and included borderline and anti-social personality disorders. The following categories were therefore assigned:
• borderline personality disorder;
• anti-social personality disorder; and
• none (no Axis II co-morbidity).
Numeric characteristics of data
All dependent variables concern nominal information and represent frequencies of non-numerical categories. indicates that no statistical difference was found between the sample characteristics of the two sample groups. The sample groups were therefore considered to be equivalent in terms of these extraneous variables.
Description of sample
Data collection
All 
Reliability and validity of the SCID
The SCID is a structured clinical interview assessing psychopathology based on clear DSM-IV-TR criteria.
Responses to questions are rated in three possible ways where a score of 1 indicates the absence of a symptom, 2 refers to its presence, but below the required threshold, and 3 denotes its full presence (Nelson-Gray, Huprich, Kissling & Ketchum, 2004:221) . Miller, Dasher, Collins, Griffiths and Brown (2001:255) report that the SCID has excellent inter-rater reliability.
In a study of 56 in-patient subjects the agreement be- 
Hypotheses
The following hypotheses were generated for univariate data:
Null hypotheses A to E
The categorical proportions of the dependent variables
A to E will not differ significantly between the treatment adherent and the treatment non-adherent groups.
Research hypotheses A to E
A to E will differ significantly between the treatment adherent and the treatment non-adherent groups. 
Statistical analysis of data
Univariate data
Significance level
To avoid capitalising on chance and thereby avoiding a Type 1 error the customary significance level of 0.05 was divided by the number of dependent variables used in the study. An alpha level of p = 0.01 (0.05/5) was therefore decided on.
Multivariate data
A logistic regression analysis was conducted to test the multiple predictive effects of statistically significant predictor variables on the criterion variable (treatment non-adherence). An alpha level of p = 0.01 was chosen.
The SPSS version 9 was employed to analyse the data.
Ethical considerations
Upon admission clients are made aware that all information can be used for future research in the field of substance abuse treatment. Informed consent was also obtained from each client. Client variables were also recorded anonymously using the file number coding. 
RESULTS
Results concerning univariate data
Hypotheses A to E Table 2 shows that significant proportional differences were found for dependent variables A and C. For the other variables there were no significant proportional differences between the adherent and the non-adherent groups. The null hypothesis is accepted in all cases except for legal history (dependent variable A) and medication on admission (dependent variable C).
Hypothesis A: Legal history
The null hypothesis A was rejected at the p = 0.01 (Fisher's exact test = 12.369). Table 3 shows that a significant difference was observed in terms of legal history between the two sample groups. Adherent patients seem to have a higher than expected criminal record (63.41% compared to the expected 48.29%). 
Hypothesis C: Medication on admission
The null hypothesis C was rejected at the p = 0.01-level (Fisher's exact test = 29.131). Table 4 indicates that the non-adherent group has a larger-than-expected incidence of using a combination of general-and psychiatric prescription medication (61.36%, as opposed to the expected 35.29%). The non-adherent group also shows a lower-than-expected incidence of abstinence from medication (22.72%, as opposed to the expected
35.23%).
This could indicate that the non-compliant group tended to overuse medication. This is confirmed if one takes into account that the vast majority (41/44 = 93.2%) of treatment non-compliant participants were found to be physically healthy on admission to the rehabilitation programme (see Table 5 ). It would, therefore, seem that treatment non-compliant patients not only have a tendency to abuse substances, but also to abuse prescription medication in general. This is further confirmed by the fact that during treatment the number of noncompliant members receiving a combination or both psycho-active and general medical prescription drugs was reduced by 15 (27-12 = 15) after admission to the treatment programme (see Table 5 ). This would indicate that these patients were using an unnecessary amount of general prescription drugs before treatment. Also, bearing in mind that no non-adherent patients were diagnosed with anxiety-based disorders (see Table 6 ), one can then confidently rule out that any of them suffered from somatoform disorders. (Somatoform disordered persons falsely believe that they have physical symptoms and therefore tend to unnecessarily resort to medication.) It, therefore, seems clear that noncompliant patients tend to abuse prescription medication in general.
Table 4 furthermore indicates that the treatment-adherent group had a higher-than-expected incidence of taking psychiatric medication (43.9%, as opposed to the expected 29.51%). The compliant group, however, did not have a history of overmedication by taking a combination of general medicine with psychiatric drugs.
Given the relatively high incidence of Axis I pathology (30/41 = 73.17%) in this group, one would assume that the medication taken by this group was appropriate to their psychiatric problems (see Table 6 ).
It is therefore evident that non-compliant patients show a tendency to overuse a combination of general and psychiatric medication, whereas compliant patients take psychiatric medication when appropriate to alleviate Axis I symptoms. It is also interesting to note that patients receiving prescribed psychiatric medication in the treatment-compliant group increased during treatment (21/41=51.22%, as opposed to 18/41=43.9% prior to the rehabilitation programme), which indicates that the psychiatrists deemed it necessary to treat the Axis I pathology with psychiatric drugs (see Table 5 ). This further confirms the notion that the medication in this group was appropriate.
Multivariate data
A logistic regression analysis was conducted to assess the relative effects of the significant predictors of Table 8 ). Table 8 indicates that the predicted probability of being non-adherent, if a combination of psychiatric and general prescription drugs is abused, was 0.9 or 90%.
Although variables of legal history and Axis I pathology do not have single significant predictor qualities, they do interact with medication on admission to enhance the predicted probabilities of certain categories. In this regard it has to be noted that the probability of nonadherence increases when certain combinations of variable categories are found. The probability of being noncompliant to treatment increases from 90% to 91.49%
if the patient lacks a criminal record but shows a tendency to abuse both psychiatric and general prescription medication. Lacking a criminal record with the abuse of a mixture of psychiatric and general prescription medication furthermore increases the probability of non-compliance to 99.97%.
In conclusion, it is therefore evident that although the general abuse of psychiatric-and other medication serves as an accurate predictor of non-compliance, its predictive effects are enhanced by some categories of legal history.
DISCUSSION
Dependent variables not affecting treatment adherence or non-adherence
Supplementary medication current
No significant differences were noted in the sample groups in terms of medication received during the treatment phase. This indicates that once patients were accepted into the treatment programme, additional medication was properly monitored by the physician and psychiatrist. Patients therefore only received necessary and appropriate medication and were not overmedicated.
It is furthermore interesting to note that the treatment adherent group's psychiatric medication was increased, whereas the treatment non-adherent group received less psychiatric and general medication after admission to the treatment programme. This confirms the notion that the treatment non-adherent group tended to use medication unnecessarily before admission. This observation is important as it impacts on the later discussion of the predictive value of the abuse of medication on treatment compliance.
Co-morbidity with Axis I psychopathology
Findings indicate that Axis I pathology does not accurately predict treatment adherence. This finding is in line with the findings of Brown et al. (2001:154) and Agosti et al. (1996:29) The finding that neither borderline nor anti-social personality disorder accurately predicts premature treatment drop-out confirms the research of Ravndal et al. (2005:183) .
Reliable predictors of treatment non-adherence
The results indicate that the single most reliable predictor of non-compliance is a tendency to over-use a mixture of psychiatric and general prescription medication. This is a novel finding that has not been researched before and does not appear in the reviewed literature on treatment non-adherence. The finding does however confirm psychodynamic factors cited in the causation and maintenance of serious substance addiction. In this regard Sadock and Sadock (2003:386) state that individuals prone to substance related disorders not only tend to regress to the oral level, but also Results furthermore show that the double combination of medication on admittance and legal history increase the predicted probability of non-adherence. In this regard results show that a combination of using both psychiatric and general prescription medication with either no criminal record or a history of arrest but no conviction increases the chance of non-compliance.
Having been arrested but not convicted could furthermore strengthen the belief that a person will be able to escape the adverse consequences of his or her actions. The intervention from parents and lawyers may furthermore strengthen the belief that others will rescue the individual and that one need not take responsibility for actions. Not being concerned with the adverse consequences of one's behaviour would then negatively impact on the client's commitment to comply with treatment. that new behavioural patterns generalize from the therapeutic to the natural environment; (4) to structure the environment so that effective behaviours, rather than dysfunctional behaviours, are reinforced; and (5) to enhance the motivation and capacities of the therapist so that effective treatment is rendered" (Sadock et al. 2003:955) .
Practical implications of the findings
EVALUATION OF THE STUDY
Positive contributions
The study provided new information with regard to the possibility that a history of unnecessary use of prescription medication prior to treatment may contribute negatively to treatment adherence. This aspect of treatment compliance has never before been investigated and the current study therefore makes a significant new contribution to the existing body of knowledge. The fact that a past history of no criminal record has an additive effect in addition to the aforementioned factor furthermore adds novel information.
It appears that no such study has previously been conducted in South Africa. This study therefore contributes to the limited research on substance abuse treatment in South Africa.
Limitations
Although the information gained from the study is significant, the study needs to be assessed within the context of its limitations. In the first place the size of the sample studied was relatively small (n = 85) and may not provide an accurate description of the general population of addicts needing drug rehabilitation. The sample consisted mainly of veteran substance abusers who were white from middle-class socio-economic backgrounds and receiving institutionalised treatment.
It is not likely that this represents South Africa's entire population of addicts eligible for rehabilitation.
The relatively small sample was mostly due to the limitations of archival research. Archival research presents its own restrictions in that only the available data can be scrutinised. Data from some files were incomplete and could, therefore, not be used for the purpose of the study. Archival information is also limited as follow-up
questions cannot be asked. This prevents deeper and more nuanced scrutiny of the material.
Axis I categories in the study are possibly too broad to determine the influence of specific disorders. Mood disorders may well contribute towards non-adherence of treatment, but more specific categories might be required to determine their role in non-compliance. In this regard future research might distinguish between categories of bipolar and unipolar disorders. This would also apply to the spectrum of eating disorders and anxiety-based disorders.
The results lastly suggest that a history of general pharmaceutical abuse may predispose an individual towards non-adherence, but it is not clear which specific medications or classes of drugs are involved. Prospective studies also need to employ a larger and more representative sample in the South African context. Such studies could also employ treatment modalities that are specifically suited to the cultural and religious needs of the South African population.
SUGGESTIONS FOR FURTHER RE-SEARCH
Qualitative research concerning characteristics of clients who prematurely drop out of treatment could add further depth to our understanding of this phenomenon.
CONCLUSION
Non-compliance in rehabilitation programmes remains a significant problem which has serious prognostic implications. Identifying reasons for non-adherence could enable care-givers to refine treatment plans in such a way that pre-mature drop-out is largely curtailed.
